What is Persistent Airflow Obstruction (PAL) and What is the Clinical Relevance? (With live Q&A)
Monday 15th January, 1-2pm
Presented by: Professor Salman Siddiqui
Persistent airflow limitation (PAL) is prevalent across all severities of asthma however it can be difficult to identify. Early management can lead to improved health outcomes for patients. To address this important topic Chiesi has invited Professor Salman Siddiqui to discuss the clinical relevance of PAL.
Closing the Gap – Inequalities in Neonatal Outcomes
Professor Karen Luyt will review information derived from specific data sets & databases to illustrate the complex nature of inequalities that we see for neonatal outcomes across different demographic and geographic regions.
Why is Early COPD Diagnosis Important in Secondary Care?
Presented by: Professor James Chalmers
Prof Chalmers discusses late presentation of COPD to secondary care and lung function trajectories leading to COPD. The presentation includes the Lancet commission and the impact of early diagnosis on patients’ long-term disease progression.
Why is Early COPD Diagnosis Important in Primary Care?
Presented by: Dr Fiona Mosgrove
Dr Mosgrove discusses the importance of early COPD diagnosis from a primary care perspective, underdiagnosis, its link with health inequalities and lack of access to diagnostic testing.
How to Set Up a Group Consultation in Respiratory Long-Term Conditions
Beverley Bostock discusses practical tips and different factors to consider on how to effectively set up a group consultation for patients with long-term respiratory conditions.
A Formula for the Delivery of Effective Group Consultations in Respiratory Long-Term Conditions
Darush Attar-Zadeh explores how the effective delivery of group consultations in respiratory conditions can overcome some barriers with time-pressured 1:1 consultations and discusses positive outcomes of group consultations through real-life examples.
Key Highlights From ECFS 2023: JLA Top 10 Research Priorities
Presented by: Dr Freddy Frost
Key highlights from the 46th European Cystic Fibrosis Society Congress 2023, with a focus on the James Lind Alliance Cystic Fibrosis Top 10 research priorities.
Transformational Medicines in Cystic Fibrosis – Learnings from HIV
Presented by: Prof. Margaret Johnson and Dr Julia Nightingale
CFTR modulators have improved the lives of many patients living with CF, however, they have presented new challenges for patients and the teams that treat them. During this webinar Prof. Margaret Johnson and Dr Julia Nightingale will explore the similarities and differences between the CF and HIV therapy areas as well as considerations for managing patients whose lives are transformed.
Excellence in COPD Reviews
Presented by: Anne Marie Marley
Anne Marie Marley discusses the importance of an COPD review with the patient in mind. She considers the stage of disease, co-morbidities, advanced care planning and forming patient goals.
Excellence in Asthma Reviews
Presented by: Frances Barrett
Frances Barrett discusses the importance of completing a regular asthma review with the patient’s goals at its centre. She reflects on asthma as a long-term condition and introduces the concept of ‘the expert patient’.
Pulmonary Rehabilitation Plus: Engaging Patients
Presented by: Dr Keir Philip
Dr Keir Philip explores the importance of engaging patients, and the opportunity of incorporating music and dance into respiratory disease management.
Inspiring Patients to Manage Their Breathlessness
Presented by: Dr Jane Watson
Dr Watson discusses the importance of motivating patients to manage their own breathlessness, and the consequent benefits of improved disease control.
Improving Neonatal Practice – An Introduction to Quality Improvement Tools
Presented by: Professor Minesh Khashu
Professor Minesh Khashu shares his experience on finding ways to improve capacity and capability within neonatal teams.
What is the Value of CBT in Respiratory Conditions and How Does it Work in Practice?
Presented by: Dr Karen Heslop-Marshall
Dr Karen Heslop-Marshall discusses the ways in which Cognitive Behavioural Therapy (CBT) can be integrated into everyday practice to help respiratory patients with their breathlessness symptoms.
Overview of CBT and its Role in Breathlessness
Presented by: Dr Sarah Baxter
Dr Sarah Baxter gives an overview of what Cognitive Behavioural Therapy (CBT) is, and how this technique is useful in helping respiratory patients manage their breathlessness.
How Can the Healthcare Community Best Support COPD Patients and Their Carers?
Presented by: Jacqui Pollington
COPD is a chronic disease that greatly impacts quality of life for both the patient as well as their carer(s), however research suggests that there is still an unmet need in supporting this important patient group. During this webinar our speaker will discuss practical ways to support COPD patients and their carers to help optimise quality of life.
Patient Perspective – BTS Annual Congress 2023
Presented by: Fiona Loud
Fiona Loud, Policy at Kidney Care UK gives her reflections from the patient’s perspective of BTS Annual Congress 2023.
Reflections on Organ Retrieval and Perfusion Technology (BTS Congress 2023)
Presented by: Mr Shahid Farid
Mr Shahid Farid’s reflections on “Organ Retrieval and Perfusion Technology” from the British Transplantation Society Annual Congress 2023 in Edinburgh.
Reflections on NHSBT Statistics from BTS Congress 2023
Presented by: Dr Catherine Boffa
Dr Catherine Boffa’s reflections on the NHSBT Statistics Presentation at the British Transplantation Society Annual Congress 2023 in Edinburgh.
Reflections on “7 of the Best Oral Presentations” from BTS 2023
Presented by: Dr Ellie Asgari
Dr Ellie Asgari’s reflections on “7 of the Best Oral Presentations” from the British Transplantation Society Annual Congress 2023 in Edinburgh.
Best Practice: Liver Transplantation and Rising Obesity (BTS Congress 2023)
Presented by: Ms Anya Adair
Anya Adair’s reflections on Best Practice in Liver Transplantation, and the impact of rising obesity, from the British Transplantation Society Congress 2023.
Keynote: Technologies To Inform Organ Utilisation (BTS Congress 2023)
Presented by: Dr Richard Baker
Dr Richard Baker’s reflections on the opening keynote lecture of the British Transplantation Society Annual Congress 2023 in Edinburgh.
Best Practice: Kidney/Pancreas (BTS Congress 2023)
Presented by: Stephen Bond
Stephen Bond’s reflections on Best Practice in Kidney/Pancreas transplant from the British Transplantation Society Annual Congress 2023 in Edinburgh.
Calne Williams Medal Presentations (BTS Congress 2023)
Presented by: Dr Varuna Aluvihare
Varuna Aluvihare’s reflections on the Calne Williams Medal Presentations at The British Transplantation Society Annual Congress 2023 in Edinburgh.
Expanding the Role of Transplant Nurses (BTS Congress 2023)
Presented by: Katie Morley
Katie Morley’s reflections on the expanding role of nurses from the British Transplantation Society Annual Congress 2023 in Edinburgh.
Creating a Net Zero GP Practice
Presented by: Dr Matt Sawyer
Dr Matt Sawyer explores different approaches as to how to achieve a Net Zero GP Practice in line with the NHS Long Term Plan.
Delivering Greener Respiratory Healthcare
Presented by: Carol Stonham
Carol Stonham discusses opportunities to reduce carbon emissions and how we can work towards carbon neutrality in respiratory care.
Demystifying the Differences Between Carbon Neutrality, Carbon Offsetting and Net Zero
Presented by: Jane Scullion
Carbon offsetting, carbon neutrality and Net Zero are terms that are gaining more traction, but what do they mean? Jane Scullion explores these terms, and the different models for achieving carbon neutrality.
Neonatal Lung Ultrasound – An Update
Presented by: Dr Mahmoud Montasser
Dr Mahmoud Montasser introduces the concept and evidence base for the use of neonatal lung ultrasound. Importantly, he describes the fundamentals of how to perform neonatal lung ultrasound and how to interpret ultrasound findings in common neonatal pathologies.
Smoking Cessation – A Patient’s Perspective
Presented by: Professor Keir Lewis
Professor Keir Lewis discusses the history of tobacco and tobacco control, how to support smoking cessation and where we are today as a health care community.
The Psychological Perspective on Adherence
Presented by: Dr Daniel O’Toole
Dr Daniel O’Toole discusses psychological perspectives of adherence, and the benefit that this can make to patient care and patient outcomes.
Clinical Challenges of Adherence
Presented by: Kirsty Honeyford
Kirsty Honeyford discusses clinical challenges of adherence, its impact on patient care and outcomes, as well as challenges in improving adherence in practice.
An Innovative Example of a Nurse-led Respiratory Service in Tameside
Presented by: Lorraine Phillips
Ms Lorraine Phillips discusses the developing role of the “traditional” respiratory nurse providing modern respiratory care as well as how the respiratory nurse works as part of the extensive care team.
Innovative Pharmacy-based Models in Scotland
Presented by: Gillian Cameron
Ms Gillian Cameron discusses the role she plays within a community team, together with the challenges faced along the way. She also talks about what the future looks like for a pharmacist working within such a team.
The Management of COPD and Co-morbidities in a Post-COVID Environment
Presented by: Professor John Hurst
Professor Hurst discusses the impact of COVID-19 on COPD patients, associated co-morbidities, and recommendations for managing COPD in a post-COVID environment.
Virtual Asthma and COPD Review Pre and Post Pandemic
Presented by: Dr Phyllis Murphie
Virtual consultations now form an important part of normal everyday clinical practice, however there are still many outstanding questions as to how to achieve optimal patient care. In this webinar, Dr Phyllis Murphie shares her perspective on what to look out for both during and after virtual consultations.
Asthma Diagnosis and Management of Associated Co-morbidities
Presented by: Professor Dominick Shaw
Professor Shaw discusses asthma care and the management of associated co-morbidities in the post-COVID environment.
Minimising Environmental Impact Across the Entire Inhaler Lifecycle
Presented by: Dr Anna Murphy
Dr Anna Murphy discusses the current inhaler policies and considerations to reduce the carbon footprint across the entire inhaler lifecycle.
Shared Decision Making in Community Care
Presented by: Miss Joanne King
Miss King discusses shared decision making in community care, how to use decision aids in clinical practice and the benefits of this for patient care and outcomes.
Shared Decision Making in Secondary Care
Presented by: Dr Ernie Wong
Dr Wong discusses shared decision making in secondary care, its impact on patient care and outcomes as well as challenges in its implementation.
Environmental Impact of SABA Overuse
Presented by: Professor Jenni Quint
Professor Jenni Quint discusses the environmental impact of poorly controlled respiratory patients and the findings of the SABINA clinical trials.
Implementation of Inhaler Switching Approaches in Primary Care for Asthma and COPD
Presented by: Dr Andy Whittamore
Dr Andy Whittamore discusses how inhaler devices can be switched effectively in primary care, ensuring the right device is chosen for the right patient.
Inhaler Switching Approaches in Asthma and COPD: What Factors to Consider?
Presented by: Professor Omar Usmani
Professor Usmani discusses the different switching approaches used to replace pMDI with DPI inhalers and their consequences on patient care.
Cystic Fibrosis, Clinical Trials & COVID-19
Presented by: Dr Damian Downey
Analysis of COVID-19 and its impact on cystic fibrosis studies. Updates on Therapeutics Development Network data in this regards and a summary of COVID-19 Antibody Response in Cystic Fibrosis study.
Viral Infections in Cystic Fibrosis
Presented by: Dr Anirban Maitra
An overview of the importance of viral infections in cystic fibrosis morbidity, the reasons for viral infections in patients with cystic fibrosis.
What does Inhaler Resistance Actually Mean?
Presented by: Mr David Harris
Mr David Harris explains in easy terms the key processes within a device during inhalation, like inhaler resistance and pressure drop.
What Is the Clinical Relevance of Inhaler Resistance?
Presented by: Dr Toby Capstick
Dr Toby Capstick explains lung physiology, inspirational flow, and shares his extensive knowledge on inhaler devices to guide you in finding the right device for the right patient.
Treatable Traits in Asthma
Presented by: Dr Dhananjay Desai
Dr Dhananjay Desai talks about the concept of treatable traits and how these can be identified using biomarkers in patients with asthma.
Patient Centricity and Treatable Traits
Presented by: Ms Vikki Knowles
Ms Vikki Knowles champions the importance of a patient centric care approach and identifying treatable traits to improve asthma management.
Small Airway Disease in Asthma
Presented by: Dr Richard Russell
Dr Richard Russell describes the importance of small airway disease in asthma as well as its diagnosis and impact on patients’ overall disease phenotype.
Integrated care systems & Multi-Disciplinary Team (MDT) working
Presented by: Dr Deepak Subramanian
Dr Deepak Subramanian talks about how the respiratory integrated service (ImpACT+) has been successfully established in South Derbyshire and Erewash.
Integrated Care from Rhetoric to Reality: Why, What, How?
Presented by: Dr Binita Kane
Dr Binita Kane introduces the concept of integrated care, explores why it is needed and how it can benefit patients and working practice alike.
Diagnostics in Asthma – Making a Correct Diagnosis
Presented by: Professor Andrew Menzies-Gow
Professor Menzies-Gow addresses challenges in making a correct asthma diagnosis, considers endotypes and the use of biomarkers towards precision medicine.
Diagnosing Asthma – Clinical Tests Revisited
Presented by: Ms Samantha Prigmore
Ms Samantha Prigmore revisits common respiratory tests to diagnose asthma and provides her perspective as to how best to utilise these tests.
Understanding Breathlessness in Asthma
Presented by: Professor Stephen Fowler
Professor Fowler explores potential causes of breathlessness by focussing on complex breathing patterns, caused by asthma or other diseases/conditions.
Inducible Laryngeal Obstruction: Chameleon Conundrums
Presented by: Dr Jemma Haines
Dr Haines describes Inducible Laryngeal Obstruction (ILO), gives examples how this condition may present in patients and explores how it can be managed.
Medicines Management Approach to the Environment
Presented by: Dr Anna Murphy
Dr Anna Murphy’s talk focusses on optimising medicines management of respiratory care, to the benefit of both patient outcomes as well as the environment.
Introduction to Global Heating and Ways to Benefit the Environment
Presented by: Dr Matt Sawyer
Dr Matt Sawyer explains global warming, the impact of F-gases within the NHS and maps out ways towards an environmentally friendly surgery.
Importance of Choosing the Right Device for the Right Patient
Presented by: Dr Azhar Saleem
Dr Azhar Saleem explores inhaler choices and shared decision making, using practical approaches to achieve improved asthma control and sustainability.
Practical Advice Around Inhaler Recycling
Presented by: Ms Carol Stonham
Ms Carol Stonham discusses inhaler recycling in her talk, touching on issues with recycling, PCRS advice and suggests ways to engage and motivate patients.
Introduction to Global Warming
Presented by: Jane Scullion
Ms Scullion explains the effects of global warming, the impact of F-Gases, and how inhalers contribute towards carbon emissions.
Patient-Centred Approach to Environmental Issues in Respiratory Care
Presented by: Dr Steve Holmes
Dr Holmes focuses on strategies to balance sustainability with patient-centred care. He discusses aspirations to reduce carbon footprint in the NHS.
High SABA Use: A Sign of the Uncontrolled Asthma Patient?
Presented by: Professor Jenni Quint
Professor Jenni Quint discusses the high use of short-acting beta agonists (SABA) and asthma control, in the context of the global and UK SABINA findings.
The Greenest Inhaler is the One a Patient Can and Will Use
Presented by: Dr Toby Capstick
Dr Capstick is building on day-to-day practical advice for on how to balance patients disease control and environmental friendly aspirations.
Impact of COVID-19 on Cystic Fibrosis Clinical Trials
Presented by: Dr Damian Downey
A presentation on the impact of COVID-19 on Cystic Fibrosis clinical trials, sponsors, participants, regulatory requirements, changing practice and research sites.
Understanding How Biomarkers Can Improve Asthma Care
Presented by: Dr David Jackson
A discussion on the relevance of blood eosinophils and FeNO as biomarkers in asthma.
The Importance of Small Airways Disease in Asthma
Presented by: Professor Salman Siddiqui
Presentation of data from the ATLANTIS study, exploring the results of various diagnostic tools on detecting small airways disease in asthmatic patients.
Perceptions and Challenges to Adherence in Asthma
Presented by: Dr Anna Murphy
Dr Anna Murphy discusses patient barriers to inhaler adherence and how to address these with personalised care, shared decision making and health coaching.
Ensuring High Quality Asthma Reviews in a Virtual Consultation
Presented by: Natalie Harper
Summary of key elements for telephone and video consultations, including basic legal/confidentiality considerations, and personal wellbeing.
Late Preterm and Early Term: Bigger Babies Have Challenges Too
Presented by: Professor Elaine Boyle
A summary of outcomes and implications for clinical practice for more mature early term and term preterm babies.
How Can Cord Management Enhance Physiological Newborn Transition?
Presented by: Professor Heike Rabe
Definitions of optimal cord management methods, resuscitation versus physiological transition, and the benefits of optimal cord management in term babies.
Results of the Cystic Fibrosis HealthHub Trial
Presented by: Dr Martin Wildman
Overview of the CF HealthHub program with the aim of helping build habits and develop adherence to treatments in Cystic Fibrosis patients.
Difficult Diagnosis in Adult Cystic Fibrosis Patients
Presented by: Dr Nicholas Simmonds
Overview of wide spectrum of Cystic Fibrosis and its impact on the ability to diagnose along with the value of nasal potential difference to diagnostic process.
Transitional Care in Cystic Fibrosis
Presented by: Louise Wooldridge
A presentation on the need for transitioning of adolescents with Cystic Fibrosis to move from child-focused care to adult oriented health care.
Digital Innovation in Cystic Fibrosis Care
Presented by: Dr Sue Madge
A look into the digital innovations in Cystic Fibrosis care, and the impact of COVID-19. Answers to why? what? and how the digital innovations have been done.
Cystic Fibrosis Transplant Care During and After COVID-19
Presented by: Dr Vicky Gerovasili
The UK and international data on the impact of COVID-19 on lung transplant mortality, post-transplant care and pre-transplant referral assessment pathway.
Feelings and Fears in Adults With and Without Cystic Fibrosis
Presented by: Professor Carlo Castellani
An overview of clinical studies, and a summary of data from a questionnaire which looked at the implications of COVID-19 in both CF and non-CF patients.
Cystic Fibrosis: Overcoming the Challenge of Providing Physio
Presented by: Ms Lisa Morrison
Reviewing the way physiotherapists work to tackle the complications of providing physiotherapy during the COVID-19 crisis whilst keeping patients safe.
Shielding in Cystic Fibrosis, A Psychological Perspective
Presented by: Dr Mandy Bryon
A look into the psychological implications of shielding during the COVID-19 pandemic, plus ways in which the psychological burden could be reduced.
Shielding in Cystic Fibrosis, A Physical Health Perspective
Presented by: Dr Carsten Schwarz
An overview of the health perspectives of COVID-19 in Cystic Fibrosis patients during the first wave of pandemic.
Please click here to access more high quality educational content in our ENGAGE Podcasts
View Podcasts